THE IKU NEURODRO
The NeuroDRO is IKU’s first DRO to tokenize a scientific breakthrough that may end Alzheimer's Disease. You will need the NEURON Token for access and commercial royalty rights of a supplement addressing a $300 billion annual market. Token economics are coming soon.
Why they’re confident this will work
Dr. Dayan Goodenowe Explains
HOW IKU’s Neurodro WORKS
You own the research
Collaborate and own a stake in the DRO’s r&d where everyone is incentivized to participate in the effort to stop Alzheimer’s and neurodegenerative disease.
You own the license
Own exclusive digital research licenses to data generated in the DRO with provenance enforced and accessed on the blockchain.
You are rewarded
Contributors will be rewarded with NEURONS, the NeuroDRO native asset required to stake, mine research, and earn royalties on contributed work.
Register and stake
Provide us your email for the right to stake the NeuroDRO. We need your email for you to claim future NEURON tokens.
research supported by
RESEARCH MADE POSSIBLE BY
Dayan B Goodenowe, PhD - Prodrome Sciences
Vijitha Senanayake, PhD - Prodrome Sciences
Siamak MahmoudianDehkordi, PhD - Duke University
Matthias Arnold, PhD - Duke University
Tyler Massaro, PhD - Duke University
Alexandra Kueider-Paisley, PhD - Duke University
Jessica D Tenenbaum, PhD - Duke University
Rima Kaddurah-Daouk, Ph.D. - Duke University
Mitchel A Kling, MD - UPENN
Yuk Yee Leung, PhD - UPENN
Li-San Wang, PhD - UPENN
Leslie M Shaw, PhD - UPENN
John Q Trojanowski, MD, PhD - UPENN
Xianlin Han, PhD - University of Texas
Kwangsik Nho, PhD - Indiana University
Rebecca Baillie, PhD - Rosa & Co LLC